Follow Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia August 31, 2026 8:00 AM EDT Company Participants Vincent Anzalone – Head of Investor Relations & VPJennifer Hellawell – Vice President of Clinical DevelopmentAndy Davis – SVP of Cardiovascular…

Finance

Economy

Markets

Fintech

Real Estate

Latest News

View More